Table 1.
Disease-associated NPC1 and NPC2 variants detected in individuals with PD, FTLD, PSP, and KORA-AGE controls.
Table 2.
Rare NPC1/2 sequence variants of unknown significance detected in individuals with PD, FTLD, PSP, and KORA-AGE controls.
Table 3.
NPC1/2 variant frequencies by groupa.
Table 4.
Clinical characteristics of PD patients carrying disease-associated NPC1/2 variants.